Literature DB >> 4261129

Cardiomyopathic Syrian hamster: a possible model of human disease.

E W Gertz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4261129     DOI: 10.1159/000393374

Source DB:  PubMed          Journal:  Prog Exp Tumor Res        ISSN: 0079-6263


× No keyword cloud information.
  6 in total

1.  Stimulatory guanine nucleotide-binding protein and adenylate cyclase activities in Bio 14.6 cardiomyopathic hamsters at the hypertrophic stage.

Authors:  T Ikegaya; A Kobayashi; R B Hong; H Masuda; M Kaneko; Y Noboru
Journal:  Mol Cell Biochem       Date:  1992-03-04       Impact factor: 3.396

Review 2.  Progress in gene therapy of dystrophic heart disease.

Authors:  Y Lai; D Duan
Journal:  Gene Ther       Date:  2012-02-09       Impact factor: 5.250

3.  AlphaB-crystallin, a low-molecular-weight heat shock protein, acts as a regulator of platelet function.

Authors:  O Kozawa; H Matsuno; M Niwa; D Hatakeyama; K Kato; T Uematsu
Journal:  Cell Stress Chaperones       Date:  2001-01       Impact factor: 3.667

4.  Verapamil induced reduction of the myocardial beta-adrenoceptor density in BIO 14.6 cardiomyopathic Syrian hamsters.

Authors:  A Kobayashi; T Nishiyama; T Ikegaya; M Kaneko; N Yamazaki
Journal:  Mol Cell Biochem       Date:  1993-04-07       Impact factor: 3.396

5.  Intrinsic connective tissue abnormalities in the heart muscle of cardiomyopathic Syrian hamsters.

Authors:  L Cohen-Gould; T F Robinson; S M Factor
Journal:  Am J Pathol       Date:  1987-05       Impact factor: 4.307

6.  Reduced Ca2+ transport across sarcolemma but enhanced spontaneous activity in cardiomyocytes isolated from left atrium-pulmonary veins tissue of myopathic hamster.

Authors:  Yue-Xia Loh; Kuo-Ho Wu; Yao-Chang Chen; Chih-Hsiung Hsu; Jeng Wei; Cheng-I Lin
Journal:  J Biomed Sci       Date:  2009-12-29       Impact factor: 8.410

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.